Search Within

David Chung

Formats
  1. Meeting Abstract (177)
  2. Journal Article (64)
  3. Research Letter (4)
  4. Correspondence (2)
  5. Book Section (1)
  6. Review (1)
Groups
  1. Bone Marrow Transplant (249)
  2. Center for Hematologic Malignancies (249)
  3. Department of Medicine (249)
  4. Hematologic Malignancies, Division of (249)
  5. Survivorship Research (221)
  6. Myeloma (190)

More Groups

People
  1. Sergio Giralt (208)
  2. Heather Landau (207)
  3. Alexander Lesokhin (175)
  4. Hani Hassoun (166)
  5. Gunjan Shah (156)
  6. Neha Korde (140)

More People

Years
  1. 2025 (4)
  2. 2024 (40)
  3. 2023 (40)
  4. 2022 (34)
  5. 2021 (15)
  6. 2020 (18)

More Years

Publications
  1. Blood (98)
  2. Clinical Lymphoma, Myeloma and Leukemia (44)
  3. Biology of Blood and Marrow Transplantation (28)
  4. Leukemia and Lymphoma (9)
  5. Journal of Clinical Oncology (8)
  6. Transplantation and Cellular Therapy (7)

More Publications

Publishers
  1. American Society of Hematology (103)
  2. Elsevier Inc. (83)
  3. Nature Publishing Group (13)
  4. American Association for Cancer Research (9)
  5. Taylor & Francis Group (9)
  6. American Society of Clinical Oncology (8)

More Publishers

Results (249)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • T-cell depleted allogeneic HSCT for patients with relapsed, high-risk multiple myeloma permits long-lasting remissions in the absence of graft-versus-host disease and provides a platform for adoptive immunotherapeutic approaches
    Meeting Abstract

    Koehne, G.; Devlin, S.; Landau, H.; Hassoun, H.; Lesokhin, A. M.; Lendvai, N.; Chung, D. J.; Bravo, C.; Giralt, S. A.
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • Phase 1 trial of carfilzomib + melphalan (CarMel) conditioning and autologous hematopoietic stem cell transplantation (AHSCT) for relapsed multiple myeloma (MM)
    Meeting Abstract

    Costa, L. J.; Landau, H.; Venkata, J. K.; Kang, Y. B.; Koehne, G.; Chung, D. J.; Lendvai, N.; Bentz, T.; Giralt, S. A.
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • Immune reconstitution after autologous stem cell transplantation for multiple myeloma
    Meeting Abstract

    Chung, D. J.; Pronschinske, K. B.; Shyer, J. A.; Wu, V.; Hassoun, H.; Landau, H.; Lendvai, N.; Lesokhin, A. M.; Koehne, G.; Giralt, S. A.; more...
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • Multiple copies of MLL is the most commonly detected cytogenetic abnormality in newly diagnosed multiple myeloma and may modify disease risk
    Meeting Abstract

    Landry, C.; Londono, D.; Devlin, S. M.; Lesokhin, A.; Lendvai, N.; Hassoun, H.; Chung, D. J.; Koehne, G.; Jhanwar, S. C.; Giralt, S. A.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • T-cell depleted allogeneic hematopoietic stem cell transplantation for patients with relapsed multiple myeloma and high-risk cytogenetics permits long-lasting remissions in the absence of graft-versus-host disease
    Meeting Abstract

    Koehne, G.; Devlin, S. M.; Landau, H.; Hassoun, H.; Lesokhin, A.; Lendvai, N.; Chung, D. J.; Bravo, C.; Giralt, S.
    Blood (2013)

    Fulltext@MSK | Save
  • Phase 1 trial of carfilzomib + high dose melphalan conditioning regimen prior to autologous hematopoietic stem cell transplantation (AHSCT) for relapsed multiple myeloma
    Meeting Abstract

    Costa, L. J.; Landau, H.; Venkata, J. K.; Kang, Y.; Koehne, G.; Chung, D. J.; Lendvai, N.; Bentz, T.; Giralt, S.
    Blood (2013)

    Fulltext@MSK | Save
  • Polyclonal immune activation and marrow plasmacytosis in multiple myeloma patients receiving long-term lenalidomide therapy: Incidence and prognostic significance
    Journal Article

    Zamarin, D.; Devlin, S. M.; Arcila, M. E.; Landau, H.; Lesokhin, A.; Lendvai, N.; Chung, D. J.; Chimento, D.; Weltz, J.; Babu, D.; more...
    Leukemia (2013)

    Fulltext@MSK | Save
  • Factors impacting stem cell mobilization failure rate and efficiency in multiple myeloma in the era of novel therapies: Experience at Memorial Sloan Kettering Cancer Center
    Journal Article

    Pozotrigo, M.; Adel, N.; Landau, H.; Lesokhin, A.; Lendvai, N.; Chung, D. J.; Chimento, D.; Riedel, E.; Chen, X.; Reich, L.; more...
    Bone Marrow Transplantation (2013)

    Fulltext@MSK | Save
  • Langerhans-type and monocyte-derived human dendritic cells have different susceptibilities to mRNA electroporation with distinct effects on maturation and activation: Implications for immunogenicity in dendritic cell-based immunotherapy
    Journal Article

    Chung, D. J.; Romano, E.; Pronschinske, K. B.; Shyer, J. A.; Mennecozzi, M.; St Angelo, E. T.; Young, J. W.
    Journal of Translational Medicine (2013)

    Fulltext@MSK | Save
  • Fractionated stem cell infusions for patients with multiple myeloma undergoing autologous stem cell transplant
    Meeting Abstract

    Wood, K.; Giralt, S. A.; Koehne, G.; Chung, D.; Hassoun, H.; Lendvai, N.; Lesokhin, A.; Hoover, E.; Devlin, S.; Landau, H.
    Biology of Blood and Marrow Transplantation (2013)

    Fulltext@MSK | Save